{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:31:17Z","timestamp":1784273477367,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1078\/0944-7113-00314","type":"journal-article","created":{"date-parts":[[2003,8,16]],"date-time":"2003-08-16T09:55:38Z","timestamp":1061027738000},"page":"440-446","source":"Crossref","is-referenced-by-count":85,"title":["Kava extracts: Safety and risks including rare hepatotoxicity"],"prefix":"10.1078","volume":"10","author":[{"given":"R.","family":"Teschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Gaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Loew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1078\/0944-7113-00314_bib1","unstructured":"Bekanntmachung der Neufassung der Allgemeinen Verwaltungsvorschrift zur Anwendung der Arzneimittelpr\u00fcfrichtlinien, May 5, 1995, Banz. Nr. 96a 1995"},{"key":"10.1078\/0944-7113-00314_bib2","series-title":"personal communication","author":"Biber","year":"2001"},{"key":"10.1078\/0944-7113-00314_bib3","first-page":"30","article-title":"Fulminantes Leberversagen nach Einnahme des pflanzlichen Heilmittels Kava-Kava","volume":"39","author":"Brauer","year":"2001","journal-title":"Z Gastroenterologie"},{"key":"10.1078\/0944-7113-00314_bib4","unstructured":"Bundesinstitiut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2002): http:\/\/www.bfarm.de\/de_ver\/arzneimittel\/amrisiken\/stufenplan\/Besch-Kava-Final.pdf"},{"key":"10.1078\/0944-7113-00314_bib5","series-title":"Streit um S\u00fcdsee-Droge Kava Presseinformation","author":"Cox","year":"2002"},{"key":"10.1078\/0944-7113-00314_bib6","unstructured":"Ernst E (2002) Marktr\u00fccknahme des pflanzlichen Anxiolytikum Kava. Nutzen unter-, Risiken \u00fcbersch\u00e4tzt? MMW-Fortschr Med 40 Nr. 41"},{"key":"10.1078\/0944-7113-00314_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bmj.322.7279.139","article-title":"Hepatitis associated with kava, a herbal remedy for anxiety","volume":"322","author":"Escher","year":"2001","journal-title":"BMJ"},{"key":"10.1078\/0944-7113-00314_bib8","series-title":"Kava information from USA June 29, 2002","author":"FDA","year":"2002"},{"key":"10.1078\/0944-7113-00314_bib9","series-title":"Pr\u00e4klinische Untersuchungen zum Nachweis des g\u00fcnstigen Risikoverh\u00e4ltnisses von Kavasedon, Kapseln gem. Auflage der Interkantonalen Kontrollstelle f\u00fcr Heilmittel (IKS) vom 18.7.00\/IKS-Nr. 53269","author":"Gebhardt","year":"2001"},{"key":"10.1078\/0944-7113-00314_bib10","series-title":"Phytopharmaka in Forschung und klinischer Anwendung III. Hrsg.","first-page":"11","article-title":"Zur Toxikologie von Phytopharmaka","author":"Habs","year":"1998"},{"key":"10.1078\/0944-7113-00314_bib11","first-page":"2056","article-title":"Kavapyrone","volume":"125","author":"H\u00e4nsel","year":"1985","journal-title":"Dtsch Apoth Ztg"},{"key":"10.1078\/0944-7113-00314_bib12","article-title":"Arzneimitteltherapie heute","volume":"Vol 6","author":"H\u00e4nsel","year":"1994"},{"key":"10.1078\/0944-7113-00314_bib13","first-page":"201","article-title":"Kava-Kava rhizoma (Kavakavawurzelstock)","volume":"Vol. 6","author":"Hoelzl","year":"1994"},{"key":"10.1078\/0944-7113-00314_bib14","first-page":"545","article-title":"Erkl\u00e4rung zum Widerruf von Kava-Extrakten","volume":"43","author":"Kommission","year":"2002","journal-title":"\u00c4rztezeitschrift f\u00fcr Naturheilverfahren"},{"key":"10.1078\/0944-7113-00314_bib15","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1055\/s-2001-16966","article-title":"Fulminantes Leberversagen nach Einnahme des pflanzlichen Antidepressivums Kava-Kava","volume":"126","author":"Kraft","year":"2001","journal-title":"Dtsch Med Wschr"},{"key":"10.1078\/0944-7113-00314_bib16","series-title":"Beitrag zur chemischen Zusammensetzung des Kava Trankes","author":"Lazar","year":"1983"},{"key":"10.1078\/0944-7113-00314_bib17","first-page":"1012","article-title":"Kava-Kava-Extrakt. Nutzen Risiko oder ein gesellschaftliches Problem","volume":"142","author":"Loew","year":"2002","journal-title":"Dtsch Apoth Ztg"},{"key":"10.1078\/0944-7113-00314_bib18","first-page":"267","article-title":"Kava-Kava Trag\u00f6die einer Fehlbeurteilung","volume":"23","author":"Loew","year":"2002","journal-title":"Zeitschrift f\u00fcr Phytotherapie"},{"key":"10.1078\/0944-7113-00314_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5694\/j.1326-5377.1988.tb93809.x","article-title":"Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community","volume":"148","author":"Mathews","year":"1988","journal-title":"Med J Aust"},{"key":"10.1078\/0944-7113-00314_bib20","unstructured":"Medicines Control Agency (MCA), London, Assessment Report July 8, 2002"},{"key":"10.1078\/0944-7113-00314_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/j.1875-9114.1998.tb03830.x","article-title":"Update: Clinically significant cytochrome P-450 drug interactions","volume":"18","author":"Michalets","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1078\/0944-7113-00314_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-135-1-200107030-00036","article-title":"Kava hepatotoxicity","volume":"135","author":"Russmann","year":"2001","journal-title":"Ann Int Med"},{"key":"10.1078\/0944-7113-00314_bib23","first-page":"29","article-title":"Akutes Leberversagen durch Kava-Kava \u2014 eine seltene Indikation zur Lebertransplantation","volume":"39","author":"Sa\u00df","year":"2001","journal-title":"Z Gastroenterologie"},{"key":"10.1078\/0944-7113-00314_bib24","first-page":"1006","article-title":"Ist Kava lebertoxisch ?","volume":"127","author":"Schmidt","year":"2002","journal-title":"Dtsch Apoth Ztg"},{"key":"10.1078\/0944-7113-00314_bib25","series-title":"Dep. Exp. Pharmacology","article-title":"Toxicology Report, Kavapyron Vomplex (Kavasedon)","author":"Sorrentino","year":"1990"},{"key":"10.1078\/0944-7113-00314_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002018-200225040-00003","article-title":"A systemetic Review of the Safety of kava extraction the treatment of Anxiety","volume":"25","author":"Stevinson","year":"2002","journal-title":"Drug and Safety"},{"key":"10.1078\/0944-7113-00314_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4414\/saez.2000.07393","article-title":"Lebersch\u00e4digungen unter Kava-Kava-Extrakten","volume":"81","author":"Stoller","year":"2000","journal-title":"Schweizerische \u00c4rztezeitung"},{"key":"10.1078\/0944-7113-00314_bib28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1055\/s-2007-1024196","article-title":"Nekrotisierende Hepatitis nach Einnahme pflanzlicher Heilmittel","volume":"123","author":"Strahl","year":"1998","journal-title":"Dtsch med Wschr"},{"key":"10.1078\/0944-7113-00314_bib29","first-page":"A3411","article-title":"Hepatotoxizit\u00e4t durch Kava- Kava","volume":"99","author":"Teschke","year":"2002","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"10.1078\/0944-7113-00314_bib30","series-title":"The Nature Foods Merchandiser April 2002","author":"Waller","year":"2002"},{"key":"10.1078\/0944-7113-00314_bib31","series-title":"The adverse effects of drugs and other chemicals on the liver","article-title":"Hepatotoxicity","author":"Zimmerman","year":"1999"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711304702469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711304702469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T20:37:39Z","timestamp":1682541459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711304702469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0944711304702469"],"URL":"https:\/\/doi.org\/10.1078\/0944-7113-00314","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}